Clinical trial
Development of Precision Medicine Platform for Pharmacogenomics of Novel Oral Anticoagulants (NOACs)
NCT04056143 is registered in ClinicalTrials.gov with Kaohsiung Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Precision Medicine Platform for Pharmacogenomics of Novel Oral Anticoagulants (NOACs)
- Lead sponsor
- Kaohsiung Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 2, 2019
- Completion date
- December 31, 2022
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulant adverse reaction